Sensitive and specific tests for COVID-19 antibodies have been approved in Europe and the US and will provide much needed data on the spread of the disease. However, they should not be used to certify an unrestricted return to work.

Dr John Ballard – Editor, Occupational Health [at Work]


This article from Occupational Health [at Work] is available free of charge.

View article here